A Century After Its Discovery, VWD Remains Dramatically Underdiagnosed Worldwide – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Omid Seidizadeh et al, adding:
”A century after its discovery, von Willebrand disease (VWD) remains dramatically underdiagnosed worldwide.
A new RPTH review highlights one of the most striking paradoxes in hematology.
Although VWD is the most common inherited bleeding disorder, the vast majority of affected individuals remain undiagnosed or misdiagnosed.
The numbers are staggering:
- Population studies estimate VWD prevalence at 0.8%–1.6%
- At least 1 in 1000 individuals likely has a clinically significant disease
- Yet global registry prevalence averages only 25.6 per million
Many patients experience:
- recurrent mucosal bleeding
- iron deficiency anemia
- chronic fatigue
- impaired quality of life
- missed school/work
- delayed surgical or obstetric recognition
Why does underdiagnosis persist after 100 years?
The review outlines several key barriers:
- Limited awareness among clinicians and the public
- Poor access to specialized VWF testing
- Biological variability of VWF levels
- Complex and heterogeneous phenotypes
- Assay variability and diagnostic inconsistency
- Misclassification as platelet disorders or hemophilia A
Meaning patients may intermittently appear ‘normal’ in routine testing.
The paper also highlights major global inequities. In low- and middle-income countries, only the most severe VWD phenotypes are typically diagnosed due to limited access to specialized laboratory infrastructure.
The message of this review is powerful:
The next century of VWD should not focus only on discovering new biology, but on ensuring patients are actually diagnosed.
A thoughtful and important review bridging bleeding disorders, women’s health, global health equity, diagnostic medicine, and laboratory hematology.”
Title: Beyond a century of discovery: the global and persistent burden of underdiagnosis in von Willebrand disease
Authors: Omid Seidizadeh, Rezan Abdul-Kadir, Pier Mannuccio Mannucci, Flora Peyvandi

Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 13:47Masoabi Sefojane: Reflections on Bleeding Disorder Care in LMICs From the WFH Africa Regional Workshop
-
May 26, 2026, 13:21Isabelle Mahé: Frailty Does Not Mean Less Anticoagulation
-
May 26, 2026, 12:32Behçet Syndrome and Thrombosis: When Inflammation Becomes a Clot
-
May 26, 2026, 12:29Priya Prasad: When Blood Becomes the Battlefield – Transfusion Medicine Saves Lives
-
May 26, 2026, 12:21Mavis Agnes Kisakye: Uganda at the WFH Regional Conference on Blood Disorders
-
May 26, 2026, 12:19Megan Adediran: Giving Hope to People Living with Bleeding Disorders
-
May 26, 2026, 11:36Abid Ur Rahman: Understanding the Coagulation Cascade and Hemostasis
-
May 26, 2026, 11:35Isaac Okello: The Real Sickle Cell Crisis Is Not Only the Disease Itself
-
May 26, 2026, 11:34Ziad Omar: PTT and aPTT Testing – Reading the Intristic Pathway of Coagulation